Septodont and Acteon to acquire Inibsa

Septodont and Acteon have signed an agreement to become shareholders of Inibsa, a global pharmaceutical group based in Barcelona, Spain. Septodont will acquire a controlling stake, with Acteon as a non-controlling shareholder. The deal is subject to regulatory approvals.

“This acquisition of control of Inibsa will expand Septodont’s development in dental products and help us further strengthen our geographical footprint.”septodontcorp.com

• 1 source
• septodontcorp.comSeptodont and Acteon announce the signing of an agreement - Septodont CorporateOlivier SCHILLER Chairman of the boardSep 3, 2024

Summarized from public sources; check the original articles before acting on it.